Pharma is politics now: Antibiotic resistance and orphan drugs in EU spotlight

EU PERSPECTIVES - The Union's landmark pharma reform moves from technical drafting to political bargaining. Negotiators are preparing for tense debates over how to reward innovation against antibiotic resistance and support treatments for rare diseases. Read more

Antibiotic resistance: talk of the town / Photo: Unsplash